GL1X · GenesisL1 explorer

UniProt Q969D9

Thymic stromal lymphopoietin (Q969D9)

Thymic stromal lymphopoietin (UniProt Q969D9): 7 experimental structures on GenesisL1, 1 ligand bound, 6 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
Q969D9
Protein
Thymic stromal lymphopoietin
Experimental structures
7
Predicted models
0
Ligands
1
Pockets
6 · 2 records with a druggable one

Structures

7 records of Q969D9 in the MolNFT archive: 7 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
5J11Structure of human TSLP in complex with TSLPR and IL-7Ralphax-ray diffractionA—3 (best 0.60)
5J11Structure of human tslp in complex with tslpr and il-7RALPHAx-ray diffractionA——
5J12Structure of human TSLP:TSLPR in complex with mouse IL-7Ralphax-ray diffractionANAG—
5J12Structure of human TSLP:TSLPR in complex with mouse il-7RALPHAx-ray diffractionA——
5J13Structural basis for TSLP antagonism by the therapeutic antibody Tezepelumab (MEDI9929 / AMG-157)x-ray diffractionA—3 (best 0.61)
5J13Structural basis for tslp antagonism by the therapeutic antibody tezepelumab (MEDI9929 / amg-157)x-ray diffractionA——
Q969D9AlphaFold monomer V2.0 prediction for thymic stromal lymphopoietin (Q969D9)———

Ligands

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · in 1 record

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.